Untitled

[biovoice]

Under the terms of the agreement, Avantor will be the primary supplier of a broad range of laboratory supplies, clinical and production materials, and services to Catalent

Avantor, Inc., a leading global provider of mission-critical products and services, has entered into a multi-year supply and services agreement with Catalent, Inc., the leader in enabling the development and supply of better treatments for patients worldwide. To know more: https://www.biovoicenews.com/under-the-terms-of-the-agreement-avantor-will-be-the-primary-supplier-of-a-broad-range-of-laboratory-supplies-clinical-and-production-materials-and-services-to-catalent/

[biovoice]

Coromandel reiterates commitment to tech led agriculture

Coromandel International Limited, India’s leading agri solutions company offering diverse products and services across the farming value chain and part of Murugappa Group continues its focus on technology adoption in agriculture and has been conducting drone trials in various locations. To know more: https://www.biovoicenews.com/coromandel-reiterates-commitment-to-tech-led-agriculture/

[biovoice]

Tushar Naik’s book ‘Medical Representative: An Indispensable Medium for the Pharmaceutical Industry’ launched

The debutant author has penned the book with the aim to help readers take their first step in building a successful career in the pharmaceutical industry. It attempts to provide step by step guidance to Medical Representatives (MR), fresh graduates and aspiring Pharma professionals to explore what would make them an indispensable medium for the pharmaceutical industry. To know more: https://www.biovoicenews.com/tushar-naiks-book-medical-representative-an-indispensable-medium-for-the-pharmaceutical-industry-launched/

[biovoice]

21.4 Lakh TB cases notified in India in 2021, 18% higher than 2020

The WHO released the Global TB Report 2022 on October 27, 2022. The Report notes the impact of the COVID-19 pandemic on the diagnosis, treatment and burden of disease for TB all over the world. The Ministry of Health and Family Welfare has taken note of the WHO Global TB Report 2022, released on October 27, 2022 and has clarified that India has, in fact, performed far better on major metrics as compared to other countries over time.

[biovoice]

Merck appoints Robert M. Davis as its new Chairman

Leading biopharmaceutical company, Merck’s board of directors has unanimously elected Robert M. Davis to serve as chairman of the board, effective December 1, 2022.

He will succeed Kenneth C. Frazier, who plans to retire on Nov. 30, 2022, after a long-tenured career at Merck that began in 1992. Frazier led the company for 10 years as President and Chief Executive Officer, from 2011 through 2021. He has served as a Merck Director since January 2011 and Chairman of its board of directors since December 2011. To know more: https://www.biovoicenews.com/merck-appoints-robert-m-davis-as-its-new-chairman/

[biovoice]

Minimally invasive neurosurgery & telesurgery changing the dynamics of SIH management

Spontaneous Intracerebral Haemorrhage (SIH) is a condition characterized by bleeding into the brain tissue and accounts for 85% of haemorrhagic stroke cases. It contributes to approximately 33% of total stroke patients and is responsible for approximately 50% of stroke-related deaths.

[biovoice]

Narayana Health initiates phase II clinical trial of CAR-T

Narayana Health, one of the leading healthcare chains in India, has announced that they have offered support to Immuneel Therapeutics, to build the most advanced CAR-T cell laboratory at the Narayana Health city Bengaluru. With this Narayana Health will offer hospital-based CAR-T cell generating laboratory and initiate the Phase II Clinical Trial.

[biovoice]

500% surge in discussions around Ebola on social media

Ebola virus disease (EVD) has spread over several key countries in the African continent such as Uganda and Congo in the last couple of months. Uganda has imposed overnight curfew and travel lockdown in two Ebola-hit districts to stop the spread of the contagious disease.

[biovoice]

BioVoice News- India's top bioscience B2B news magazine | October 2022 Issue 1 Volume 3

To refresh the journey of Indian vaccines, the current edition of the magazine dives deeper into the impact created by the Indian vaccine industry, especially its role as a savior during the scary times of Covid-19.This edition is also full of aspirational stories. The ‘Lab-made Seafood’ is an interesting example of how innovative ideas in food technology sector are being currently tested. The Special Startup Series features a Pune based young startup, Ahammune Biosciences that has innovated a promising drug for Vitiligo. Role of digitalization in accelerating the growth of the life sciences sector finds a special place too. The exclusive interviews with leading names of the industry, Merck Life sciences India and Veeda Clinical Research reveal fresh details about their respective initiatives. To know more: https://bit.ly/bv-oct-22

[biovoice]

[biovoice]

BioVoice News October 2022 Issue 1 Volume 3

This edition of BioVoice magazine in its ‘Cover Story’, takes a deep dive into India’s vaccine industry. In the BioChat, Mr Ajay Tandon, Man